BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3534879)

  • 1. Metalloendoprotease inhibitors that block fusion also prevent biochemical differentiation in L6 myoblasts.
    Baldwin E; Kayalar C
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8029-33. PubMed ID: 3534879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble metalloendoprotease required in myoblast fusion remains intracellular.
    Farach HA; Strittmatter WJ
    Biochem Biophys Res Commun; 1987 Aug; 147(1):474-8. PubMed ID: 3307780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme.
    Kayalar C; Wong WT
    J Biol Chem; 1989 May; 264(15):8928-34. PubMed ID: 2656690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between fusion and the developmental regulation of membrane glycoproteins in L6 myoblasts.
    Rosenberg J; Szabo A; Rheuark D; Kayalar C
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8409-13. PubMed ID: 3909144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat myoblast fusion requires metalloendoprotease activity.
    Couch CB; Strittmatter WJ
    Cell; 1983 Jan; 32(1):257-65. PubMed ID: 6337722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors.
    Kayalar C; Wong WT; Hendrickson L
    J Cell Biochem; 1990 Nov; 44(3):137-51. PubMed ID: 2269683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific blockers of myoblast fusion inhibit a soluble and not the membrane-associated metalloendoprotease in myoblasts.
    Couch CB; Strittmatter WJ
    J Biol Chem; 1984 May; 259(9):5396-9. PubMed ID: 6371004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of metalloendoprotease activity prevent K+-stimulated neurotransmitter release from the retina of Xenopus laevis.
    Frederick JM; Hollyfield JG; Strittmatter WJ
    J Neurosci; 1984 Dec; 4(12):3112-9. PubMed ID: 6150072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for metalloendoprotease in exocytosis: evidence in mast cells and adrenal chromaffin cells.
    Mundy DI; Strittmatter WJ
    Cell; 1985 Mar; 40(3):645-56. PubMed ID: 2578889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of medium conditions and differentiation in the rat myogenic cell line L6.
    Pinset C; Whalen RG
    Dev Biol; 1984 Apr; 102(2):269-77. PubMed ID: 6706000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of myoblast phenotype by dimethyl sulfoxide.
    Miranda AF; Nette EG; Khan S; Brockbank K; Schonberg M
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3826-30. PubMed ID: 278996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors implicate metalloendoprotease in synaptic transmission at the mammalian neuromuscular junction.
    Baxter DA; Johnston D; Strittmatter WJ
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4174-8. PubMed ID: 6306666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intracellular proteases in differentiation of L6 myoblast cells.
    Ebisui C; Tsujinaka T; Kido Y; Iijima S; Yano M; Shibata H; Tanaka T; Mori T
    Biochem Mol Biol Int; 1994 Mar; 32(3):515-21. PubMed ID: 8032318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
    Jochen A; Berhanu P
    Biochem Biophys Res Commun; 1987 Jan; 142(1):205-12. PubMed ID: 3545203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloendoprotease inhibitors block fast axonal transport.
    Hammerschlag R; Bolen FA; Stone GC
    J Neurochem; 1989 Jan; 52(1):268-73. PubMed ID: 2783254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of myogenesis in vitro: reversible inhibition by DMSO.
    Blau HM; Epstein CJ
    Cell; 1979 May; 17(1):95-108. PubMed ID: 455462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantal division and a postmitotic state in myoblast differentiation.
    Brunk CF
    Differentiation; 1979; 14(1-2):95-9. PubMed ID: 478214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of metalloendoproteases block spiculogenesis in sea urchin primary mesenchyme cells.
    Roe JL; Park HR; Strittmatter WJ; Lennarz WJ
    Exp Cell Res; 1989 Apr; 181(2):542-50. PubMed ID: 2924802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral protease inhibitors prevent l6 muscle cell fusion by reducing calpain activity.
    Colby-Germinario SP; Chalifour LE; Antonecchia A; Germinario RJ
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1057-62. PubMed ID: 15585096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique subset of developmentally regulated surface proteins turns over rapidly during fusion of the L6 rat myoblast cell line.
    Pauw PG; David JD
    Exp Cell Res; 1990 Jan; 186(1):74-82. PubMed ID: 2298238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.